Application

PRIMER

Arsenal Biosciences, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97002895
Filing Date: 08/30/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97002895
MARK INFORMATION
*MARK PrimeR
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT PrimeR
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Arsenal Biosciences, Inc.
INTERNAL ADDRESS Suite 700
*MAILING ADDRESS 2 Tower Place
*CITY South San Francisco
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94080
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions.
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME R. Gwen Peterson
ATTORNEY DOCKET NUMBER 1268205
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Kilpatrick Townsend & Stockton LLP
INTERNAL ADDRESS Suite 600
STREET 2175 North California Boulevard
CITY Walnut Creek
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94596
PHONE 925-472-5000
FAX (925) 472-8895
EMAIL ADDRESS rpeterson@kilpatricktownsend.com
CORRESPONDENCE INFORMATION
NAME R. Gwen Peterson
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE rpeterson@kilpatricktownsend.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmadmin@kilpatricktownsend.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Gene H. Yee/
SIGNATORY'S NAME Yee, Gene H.
SIGNATORY'S POSITION Senior Director of Intellectual Property
SIGNATORY'S PHONE NUMBER 650-240-8844
DATE SIGNED 08/30/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97002895
Filing Date: 08/30/2021

To the Commissioner for Trademarks:

MARK: PrimeR (Standard Characters, see mark)
The literal element of the mark consists of PrimeR. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Arsenal Biosciences, Inc., a corporation of Delaware, having an address of
      Suite 700
      2 Tower Place
      South San Francisco, California 94080
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: R. Gwen Peterson. R. Gwen Peterson of Kilpatrick Townsend & Stockton LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      Suite 600
      2175 North California Boulevard
      Walnut Creek, California 94596
      United States
      925-472-5000(phone)
      (925) 472-8895(fax)
      rpeterson@kilpatricktownsend.com
The docket/reference number is 1268205.
R. Gwen Peterson submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      R. Gwen Peterson
       PRIMARY EMAIL FOR CORRESPONDENCE: rpeterson@kilpatricktownsend.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmadmin@kilpatricktownsend.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Gene H. Yee/   Date: 08/30/2021
Signatory's Name: Yee, Gene H.
Signatory's Position: Senior Director of Intellectual Property
Signatory's Phone Number: 650-240-8844
Signature method: Sent to third party for signature
Payment Sale Number: 97002895
Payment Accounting Date: 08/30/2021

Serial Number: 97002895
Internet Transmission Date: Mon Aug 30 21:30:40 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202108302130405
44737-97002895-781388235c805b6c69e6ff368
857bfd1bacffbf88ab3a1cd9bcbcf542412883e-
CC-30394922-20210824144825026541

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed